| Pancancer survival analysis of cancer hallmark genes Á Nagy, G Munkácsy, B Győrffy Scientific reports 11 (1), 6047, 2021 | 993 | 2021 |
| miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients A Lánczky, Á Nagy, G Bottai, G Munkácsy, A Szabó, L Santarpia, B Győrffy Breast cancer research and treatment 160, 439-446, 2016 | 768 | 2016 |
| Pancancer survival analysis of cancer hallmark genes. bioRxiv A Nagy, G Munkacsy, B Gyorffy Probe ID: 206571_s_at p-value 3, 2020 | 247 | 2020 |
| Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes B Győrffy, G Bottai, T Fleischer, G Munkácsy, J Budczies, L Paladini, ... International journal of cancer 138 (1), 87-97, 2016 | 169 | 2016 |
| PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer G Munkácsy, R Abdul-Ghani, Z Mihály, B Tegze, O Tchernitsa, P Surowiak, ... British journal of cancer 102 (2), 361-368, 2010 | 73 | 2010 |
| TP53 mutation hits energy metabolism and increases glycolysis in breast cancer H Harami-Papp, LS Pongor, G Munkácsy, G Horváth, ÁM Nagy, A Ambrus, ... Oncotarget 7 (41), 67183, 2016 | 65 | 2016 |
| Meta‐analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples T Fekete, E Rásó, I Pete, B Tegze, I Liko, G Munkácsy, N Sipos, J Rigó Jr, ... International journal of cancer 131 (1), 95-105, 2012 | 62 | 2012 |
| DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer O Menyhart, J Budczies, G Munkácsy, FJ Esteva, A Szabó, TP Miquel, ... Oncotarget 8 (44), 77207, 2017 | 36 | 2017 |
| Gene expression profiling in early breast cancer—patient stratification based on molecular and tumor microenvironment features G Munkácsy, L Santarpia, B Győrffy Biomedicines 10 (2), 248, 2022 | 28 | 2022 |
| Validation of RNAi silencing efficiency using gene array data shows 18.5% failure rate across 429 independent experiments G Munkácsy, Z Sztupinszki, P Herman, B Bán, Z Pénzváltó, N Szarvas, ... Molecular Therapy-Nucleic Acids 5, 2016 | 17 | 2016 |
| Therapeutic potential of tumor metabolic reprogramming in triple-negative breast cancer G Munkácsy, L Santarpia, B Győrffy International Journal of Molecular Sciences 24 (8), 6945, 2023 | 16 | 2023 |
| Gene expression-based prognostic and predictive tools in breast cancer G Munkácsy, MA Szász, O Menyhárt Breast cancer 22, 245-252, 2015 | 14 | 2015 |
| Promoter analysis suggests the implication of NFkappaB/C-Rel transcription factors in biliary atresia. A Gyorffy, Z Baranyai, A Cseh, G Munkacsy, F Jakab, Z Tulassay, ... Hepato-gastroenterology 55 (85), 1189-1192, 2008 | 11 | 2008 |
| RNA interference and its clinical applications G Munkácsy, Z Tulassay, B Győrffy Orvosi Hetilap 148 (47), 2235-2240, 2007 | 7 | 2007 |
| Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting LS Pongor, G Munkácsy, I Vereczkey, I Pete, B Győrffy Scientific RepoRtS 10 (1), 14403, 2020 | 6 | 2020 |
| Harnessing Hyperthermia: Molecular, Cellular, and Immunological Insights for Enhanced Anticancer Therapies S Lukácsi, G Munkácsy, B Győrffy Integrative Cancer Therapies 23, 15347354241242094, 2024 | 4 | 2024 |
| Independent validation of induced overexpression efficiency across 242 experiments shows a success rate of 39% G Munkácsy, P Herman, B Győrffy Scientific Reports 9 (1), 343, 2019 | 4 | 2019 |
| DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer B Gyorffy, G Munkacsy, FJ Esteva, TP Miquel, O Menyhart CANCER RESEARCH 76, 2016 | 3 | 2016 |
| 243 Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes B Gyorffy, G Bottai, T Fleischer, G Munkacsy, L Paladini, AL Bressen-Dale, ... European Journal of Cancer 3 (51), S41, 2015 | 3 | 2015 |
| Proteotranscriptomic discrimination of tumor and normal tissues in renal cell carcinoma Á Bartha, Z Darula, G Munkácsy, É Klement, P Nyirády, B Győrffy International journal of molecular sciences 24 (5), 4488, 2023 | 2 | 2023 |
Balázs Győrffy MD PhDClarivate Highly Cited, Semmelweis, PTE, HUN-REN, ELIXIR, Hungarian Academy of Sciences在 ttk.mta.hu 的电子邮件经过验证
